Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 56 (RPL21P56)

Target
RPL21P56
Molecular classification
Other, Pseudogene
01

Overview

Ribosomal protein L21 pseudogene 56 (RPL21P56) is a processed pseudogene of the functional ribosomal protein L21 gene (RPL21). Pseudogenes like RPL21P56 are genomic DNA sequences similar to normal genes but, due to mutations or incomplete sequences, they do not encode functional proteins. RPL21P56 is not expressed as a protein and has no known biological or clinical function. The existence of multiple pseudogenes is a common feature for many ribosomal protein genes in the human genome[2][4][1].

Other names
RPL21_21_549RPL21P56
02

Mechanism of action

None (no mechanism of action, since it is not a functional gene product)

03

Biological functions

None (as a pseudogene, RPL21P56 has no known biological function; it does not encode a protein involved in cellular processes)
04

Disease associations

None (no direct disease association; note that mutations in the real RPL21 gene, not the pseudogene, are associated with Hypotrichosis simplex of the scalp)
05

Safety considerations

None
06

Interacting drugs

None (no known drugs target this pseudogene)
07

Biomarkers

None

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 56 (RPL21P56).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 56 (RPL21P56).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call